Abstract
Transactions announcements can signal the health of an industry. This article examines all biotechnology transaction announcements occurring in the U.S. between 2010 and 2017. A baseline comparison to the pre-financial crisis transaction announcements of 2002 through 2006 is provided. Our study finds a significant rebound in the number of transactions during the time of study and continuing shifts by those on both ends of the transactions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
